In 2015, Marshall et al. (2015) identified a cysteine-modifying MAPT mutation altering cysteine-291 to arginine in a patient diagnosed with corticobasal degeneration (CBD) with apraxia of speech. This evidence concerns the gene MAPT and red-green color blindness.